IL-1 protects from fatal systemic candidiasis in mice by inhibiting oxidative phosphorylation and hypoxia

S Sofia Horn M Mareike Schmid I Ivan Berest (Department of Biology, Institute of Molecular Health Sciences, ETH Zurich) F Federica Piattini J Jing Zhang K Katrien de Bock O Olivier Devuyst (Department of Physiology, University of Zurich, Zurich, Switzerland) S Stellor Nlandu Khodo J Jan Kisielow (Repertoire Immune Medicines, Schlieren, Switzerland.) M Manfred Kopf (Department of Biology, Institute of Molecular Health Sciences, ETH Zurich)

Abstract

Abstract Invasive C. albicans infections result in high mortality rates. While IL-1 is important to combat C. albicans infections, the underlying mechanisms remain unclear. Using global and conditional Il1r1 knockouts in mice, here we show that IL-1R signaling in non-hematopoietic cells in the kidney and brain is crucial for a protective response. In the kidney, endothelial IL-1R contributes to fungal clearance independent of neutrophil recruitment, while IL-1R in hematopoietic cells is dispensable. IL-1R signaling indirectly recruits neutrophils and monocytes in the brain by regulating chemokines and adhesion molecules. Single-nucleus-RNA-sequencing data implicates excessive metabolic activity and oxidative phosphorylation across all cell types in the kidney of Il1r1-deficient mice within a few hours upon infection, with associated, localized hypoxia at infection foci. Lastly, we find that hypoxia promotes fungal growth and pathogenicity. In summary, our results show that IL-1R-signaling in non-hematopoietic cells is required to prevent fatal candidiasis by inhibiting a metabolic shift, including excessive oxidative phosphorylation and hypoxia.

Article Details

Volume / Issue Vol. 16, Issue 1
Published March 17, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (10)

S

Sofia Horn

M

Mareike Schmid

I

Ivan Berest

Department of Biology, Institute of Molecular Health Sciences, ETH Zurich

F

Federica Piattini

J

Jing Zhang

K

Katrien de Bock

O

Olivier Devuyst

Department of Physiology, University of Zurich, Zurich, Switzerland

S

Stellor Nlandu Khodo

J

Jan Kisielow

Repertoire Immune Medicines, Schlieren, Switzerland.

M

Manfred Kopf

Department of Biology, Institute of Molecular Health Sciences, ETH Zurich